CIK: 0001017645 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 11, 2023
Total Value ($000): $6,344,908 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ENGAGESMART | 90,271,540 | $1,723,284 | 27.2% | $34.06 | — | COM | 29283F103 |
| DLO | DLOCAL | 63,906,695 | $779,981 | 12.3% | $34.47 | -63.4% | CL A | G29018101 |
| — | SQUARESPACE | 22,361,073 | $705,268 | 11.1% | $59.41 | — | CL A | 85225A107 |
| XP | XP, INC | 29,617,733 | $694,832 | 11.0% | $31.26 | -45.7% | CL A | G98239109 |
| — | HIRERIGHT | 32,109,898 | $363,163 | 5.7% | $15.69 | — | COM | 433537107 |
| ALHC | ALIGNMENT HEALTHCARE | 60,993,323 | $350,712 | 5.5% | $19.55 | -66.9% | COM | 01625V104 |
| ALKT | ALKAMI | 18,729,806 | $306,982 | 4.8% | $36.66 | -62.4% | COM | 01644J108 |
| EWCZ | EUROPEAN WAX CENTER | 13,110,492 | $244,248 | 3.8% | $22.36 | -20.0% | CL A | 29882P106 |
| MBLY | MOBILEYE | 4,761,905 | $182,952 | 2.9% | $30.35 | +33.7% | CL A | 60741F104 |
| — | KARUNA THERAPEUTICS | 726,958 | $157,641 | 2.5% | $213.03 | — | COM | 48576A100 |
| YOU | CLEAR SECURE | 4,861,120 | $112,632 | 1.8% | $35.76 | -37.5% | CL A | 18467V109 |
| — | AKERO THERAPEUTICS | 1,785,714 | $83,375 | 1.3% | $46.69 | — | ORD | 00973Y108 |
| DUOL | DUOLINGO | 580,642 | $82,997 | 1.3% | $88.33 | +62.2% | CL A | 26603R106 |
| PHVS | PHARVARIS | 4,406,252 | $66,711 | 1.1% | $21.62 | -55.5% | COM | N69605108 |
| — | GINKGO BIOWORKS | 32,319,896 | $60,115 | 0.9% | $11.59 | — | CL A | 37611X100 |
| CNTA | CENTESSA PHARMACEUTICALS | 9,681,818 | $59,930 | 0.9% | $17.55 | — | Sponsored ADS | 152309100 |
| IMCR | IMMUNOCORE | 950,000 | $56,962 | 0.9% | $42.57 | — | ADS | 45258D105 |
| — | ARCO PLATFORM LIMITED | 4,103,366 | $49,815 | 0.8% | $13.88 | — | CL A | G04553106 |
| HCM | HUTCHMED | 4,000,000 | $48,000 | 0.8% | $36.61 | — | Sponsored ADS | 44842L103 |
| RPRX | ROYALTY PHARMA | 1,500,000 | $46,110 | 0.7% | $49.50 | -31.6% | SHS CLASS A | G7709Q104 |
| FUTU | FUTU | 1,111,544 | $44,173 | 0.7% | $40.65 | — | SPON ADS CL A | 36118L106 |
| — | ACELYRIN | 1,500,000 | $31,350 | 0.5% | $20.90 | — | ORD | 00445A100 |
| RSKD | RISKIFIED | 5,324,998 | $25,879 | 0.4% | $28.06 | -82.1% | CL A | M8216R109 |
| OPEN | OPENDOOR | 6,321,519 | $25,413 | 0.4% | $21.67 | -89.6% | COM | 683712103 |
| BLND | BLEND LABS | 19,132,440 | $18,122 | 0.3% | $10.77 | -91.8% | CL A | 09352U108 |
| — | THIRD HARMONIC BIO | 2,958,762 | $14,232 | 0.2% | $18.97 | — | COM | 88427A107 |
| — | WISH | 609,615 | $4,011 | 0.1% | $6.58 | — | CL A | 21077C305 |
| — | BUZZFEED | 7,862,502 | $3,971 | 0.1% | $5.33 | — | CL A | 12430A102 |
| GROV | GROVE COLLABORATIVE | 936,020 | $1,657 | 0.0% | $2.20 | 0.0% | CL A | 39957D201 |
| ADAG | ADAGENE | 264,000 | $391 | 0.0% | $17.95 | — | ADR | 005329107 |